KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) EBT Margin (2016 - 2025)

Biolife Solutions (BLFS) has disclosed EBT Margin for 16 consecutive years, with 17.9% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 1479.0% to 17.9% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 12.56% through Dec 2025, down 74.0% year-over-year, with the annual reading at 12.56% for FY2025, 74.0% down from the prior year.
  • EBT Margin for Q4 2025 was 17.9% at Biolife Solutions, up from 2.5% in the prior quarter.
  • The five-year high for EBT Margin was 17.9% in Q4 2025, with the low at 219.83% in Q4 2022.
  • Average EBT Margin over 5 years is 43.94%, with a median of 20.5% recorded in 2022.
  • The sharpest move saw EBT Margin tumbled -19006bps in 2021, then surged 17016bps in 2023.
  • Over 5 years, EBT Margin stood at 49.12% in 2021, then crashed by -348bps to 219.83% in 2022, then soared by 43bps to 126.02% in 2023, then skyrocketed by 102bps to 3.1% in 2024, then surged by 477bps to 17.9% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 17.9%, 2.5%, and 61.81% for Q4 2025, Q3 2025, and Q2 2025 respectively.